The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvanced Medical Solutions Group Regulatory News (AMS)

Share Price Information for Advanced Medical Solutions Group (AMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 211.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.474%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 211.00
AMS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

19 Dec 2011 11:58

RNS Number : 2390U
Advanced Medical Solutions Grp PLC
19 December 2011
 



19 December 2011

 

Advanced Medical Solutions Group plc

("AMS" or the "Company")

 

Result of General Meeting

 

The Board of AMS (AIM: AMS), the global medical technology company, is pleased to announce that the Resolutions proposed at the General Meeting held today at 11.00 a.m. at the offices of Investec Bank plc, 2 Gresham Street, London EC2V 7QP, in connection with the proposed Placing to raise approximately £34.0 million for the proposed acquisition of RESORBA announced on 2 December 2011, were duly passed without amendment.

 

The Placing remains conditional upon the Placing Agreement becoming unconditional in all respects and upon Admission.

 

Application has been made to AIM for the Admission of 48,214,415 ordinary shares of 5 pence each in connection with the Placing and Acquisition. It is expected that Admission will become effective on 20 December 2011 and that dealings in the New Ordinary Shares will commence at 8.00 a.m. on 20 December 2011.

 

The New Ordinary Shares (in uncertificated form) are expected to be credited to CREST accounts on or around 8.00 a.m. on 20 December 2011 and definitive share certificates for the New Ordinary Shares (in certificated form) are expected to be despatched to certificated shareholders by no later than 4 January 2012.

 

The New Ordinary Shares will be issued credited as fully paid and will, on issue, rank equally in all respects with the Existing Ordinary Shares, including the right to receive all dividends or other distributions made, paid or declared after Admission.

 

On Admission, the Company's issued share capital will consist of 203,516,367 Ordinary Shares.

 

For further information, please contact:

Advanced Medical Solutions Group plc

Chris Meredith, Chief Executive Officer

Mary Tavener, Finance Director

 

Tel: +44 (0) 1606 545508

Investec Bank plc (NOMAD) and Broker

Gary Clarence

Patrick Robb

Daniel Adams

Cara Griffiths

 

Tel: +44 (0) 20 7597 5970

Tavistock Communications

John West

Chris Munden

Andrew Dunn

 

Tel: +44 (0) 20 7920 3150

 

Investec Bank plc, which is authorised and regulated in the United Kingdom by the FSA, is acting as nominated adviser, broker and underwriter to AMS in relation to the Placing and Admission and is not acting for any other persons in relation to the Placing and Admission. Investec Bank plc is acting exclusively for AMS and for no one else in relation to the matters described in this announcement and is not advising any other person and accordingly will not be responsible to anyone other than AMS for providing the protections afforded to clients of Investec Bank plc, or for providing advice in relation to the contents of this announcement or any matter referred to in it. The responsibilities of Investec Bank plc as AMS's nominated adviser and broker under the AIM Rules for Companies and the AIM Rules for Nominated Advisers are owed solely to the London Stock Exchange and are not owed to AMS or to any Director, Shareholder or any other person, in respect of any decision to acquire or dispose of shares in the capital of AMS in reliance on any part of this announcement, or otherwise.

 

No liability is accepted by Investec Bank plc nor does it make any representation or warranty, express or implied, in relation to, the contents of this announcement, including its accuracy, completeness or verification or for any other statement made or purported to be made by it, or on its behalf, in connection with the Company and the Placing and accordingly Investec Bank plc disclaims all and any responsibility or liability whether arising in tort, contract or otherwise which it might otherwise have in respect of this announcement or any such statement. Investec Bank plc has not authorised the contents, or any part, of this announcement. Investec Bank plc may, in accordance with applicable legal and regulatory provisions, engage in transactions in relation to the Ordinary Shares (including the Placing Shares) and/or related instruments for its own account for the purposes of hedging its underwriting exposure or otherwise. Except as required by applicable law or regulation, Investec Bank plc does not propose to make any public disclosure in relation to any such transactions.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFKLFFFLFEFBE
Date   Source Headline
8th Jan 20215:37 pmRNSHolding(s) in Company
31st Dec 202010:00 amRNSTotal Voting Rights
15th Dec 20209:47 amRNSHolding(s) in Company
30th Nov 20201:29 pmRNSTotal Voting Rights
23rd Nov 20207:00 amRNSAMS Acquisition of Raleigh Coatings
20th Nov 20207:00 amRNSCE mark approval for Silicone PHMB Foam Dressing
16th Nov 20201:29 pmRNSHoldings in Company
19th Oct 20203:29 pmRNSHolding(s) in Company
16th Sep 20207:00 amRNSInterim Results
15th Sep 20202:48 pmRNSBlock listing Interim Review
3rd Sep 20207:00 amRNSNotice of Results
14th Aug 202012:02 pmRNSPrice Monitoring Extension
4th Aug 20207:00 amRNSUK and US Patents Granted for LiquiBand® Exceed
31st Jul 20201:29 pmRNSTotal Voting Rights
9th Jul 20207:00 amRNSTrading Update
30th Jun 20205:52 pmRNSTotal Voting Rights
19th Jun 202012:02 pmRNSPrice Monitoring Extension
15th Jun 202012:02 pmRNSPrice Monitoring Extension
10th Jun 202011:30 amRNSResult of Annual General Meeting
10th Jun 20207:00 amRNSAGM Trading and US LiquiBand® Update
29th May 20202:17 pmRNSTotal Voting Rights
18th May 20207:00 amRNSAnnual Report, AGM and Board Change
12th May 20206:16 pmRNSDirector/PDMR Shareholding
11th May 20204:01 pmRNSDirector/PDMR Shareholding
30th Apr 20202:00 pmRNSTotal Voting Rights
17th Apr 20204:30 pmRNSDirector/PDMR Shareholding
14th Apr 20207:00 amRNSPCA Dealing
6th Apr 20209:26 amRNSDirector/PDMR and PCA Shareholding
6th Apr 20207:01 amRNSClinical Development Programme
6th Apr 20207:00 amRNSDirector/PDMR Shareholding
2nd Apr 20207:00 amRNSCOVID-19 Update
30th Mar 20209:06 amRNSHoldings in Company
13th Mar 20205:00 pmRNSHolding(s) in Company
11th Mar 20207:00 amRNSUnaudited Preliminary Results
10th Mar 20207:00 amRNSBlock listing Interim Review
10th Mar 20207:00 amRNSFDA Approval of LiquiBand® Rapid(TM)
11th Feb 202010:03 amRNSHolding(s) in Company
15th Jan 20207:00 amRNSYear End Trading Update
31st Dec 201912:18 pmRNSTotal Voting Rights
2nd Dec 20197:00 amRNSAcquisition of Biomatlante SA
29th Nov 20193:08 pmRNSTotal Voting Rights
29th Nov 20197:00 amRNSThird party sterilisation failure
31st Oct 20193:13 pmRNSTotal Voting Rights
31st Oct 20193:09 pmRNSHolding(s) in Company
16th Sep 201911:15 amRNSHolding(s) in Company
16th Sep 20197:00 amRNSDirector/PDMR Shareholding
11th Sep 20197:00 amRNSInterim Results
6th Sep 20197:00 amRNSBlock listing Interim Review
8th Aug 20197:00 amRNSNotice of Interim Results
31st Jul 20195:52 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.